Support Your Metabolism with Clinically-Studied Ingredients

Mitolyn — 6 plant-based nutrients to boost mitochondrial health, energy & natural fat burning.

★★★★★ 127,000+ customers · 90-day money-back guarantee

Dr. Paul Hassoun, M.D

Internal Medicine Baltimore, MD Male

NPI: 1083664387

Total Payments

$70,581

2024 Payments

$11,320

Companies

Transactions

Medicare Patients

677

Medicare Billing

$108,614

Payment Breakdown by Category

Consulting$49,578 (70.2%)

Travel$11,718 (16.6%)

Other$7,225 (10.2%)

Food & Beverage$2,060 (2.9%)

Payments by Nature

Nature of Payment	Amount	Transactions	Share
Consulting Fee	$49,578	20	70.2%
Travel and Lodging	$11,718	13	16.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$7,225	1	10.2%
Food and Beverage	$2,060	34	2.9%

Top Paying Companies

Company	Total	Records	Latest Year
Merck Sharp & Dohme LLC	$61,442	43	$0 (2024)
United Therapeutics Corporation	$6,706	14	$0 (2024)
Janssen Research & Development, LLC	$1,240	1	$0 (2022)
Actelion Pharmaceuticals US, Inc.	$880.55	8	$0 (2017)
Bayer Healthcare Pharmaceuticals Inc.	$200.00	1	$0 (2023)
Gilead Sciences, Inc.	$112.50	1	$0 (2018)

Payment History by Year

Year	Amount	Transactions	Top Company
2024	$11,320	9	Merck Sharp & Dohme LLC ($7,666)
2023	$6,820	12	Merck Sharp & Dohme LLC ($6,324)
2022	$10,347	18	Merck Sharp & Dohme LLC ($6,498)
2021	$16,253	3	Merck Sharp & Dohme LLC ($16,150)
2020	$2,125	1	Merck Sharp & Dohme Corporation ($2,125)
2019	$22,722	16	Merck Sharp & Dohme Corporation ($22,679)
2018	$112.50	1	Gilead Sciences, Inc. ($112.50)
2017	$880.55	8	Actelion Pharmaceuticals US, Inc. ($880.55)

All Payment Transactions

68 individual payment records from CMS Open Payments — Page 1 of 3

Date	Company	Product	Nature	Form	Amount	Type
12/18/2024	Merck Sharp & Dohme LLC	—	Consulting Fee	Cash or cash equivalent	$1,000.00	General
Category: CARDIOVASCULAR
10/23/2024	Merck Sharp & Dohme LLC	—	Consulting Fee	Cash or cash equivalent	$5,490.00	General
10/23/2024	Merck Sharp & Dohme LLC	—	Travel and Lodging	Cash or cash equivalent	$150.00	General
10/16/2024	Merck Sharp & Dohme LLC	WINREVAIR (Biological)	Travel and Lodging	In-kind items and services	$388.43	General
Category: CARDIOVASCULAR
10/15/2024	United Therapeutics Corporation	—	Consulting Fee	Cash or cash equivalent	$3,480.00	General
09/10/2024	United Therapeutics Corporation	—	Food and Beverage	In-kind items and services	$104.87	General
09/06/2024	United Therapeutics Corporation	—	Food and Beverage	In-kind items and services	$48.00	General
09/06/2024	United Therapeutics Corporation	—	Food and Beverage	In-kind items and services	$21.33	General
03/25/2024	Merck Sharp & Dohme LLC	—	Consulting Fee	Cash or cash equivalent	$637.50	General
Category: CARDIOVASCULAR
12/18/2023	Merck Sharp & Dohme LLC	—	Consulting Fee	Cash or cash equivalent	$5,490.00	General
12/18/2023	Merck Sharp & Dohme LLC	—	Travel and Lodging	Cash or cash equivalent	$150.00	General
12/08/2023	Merck Sharp & Dohme LLC	—	Food and Beverage	In-kind items and services	$124.03	General
12/08/2023	Merck Sharp & Dohme LLC	—	Food and Beverage	In-kind items and services	$49.99	General
12/08/2023	Merck Sharp & Dohme LLC	—	Food and Beverage	In-kind items and services	$34.99	General
12/08/2023	Merck Sharp & Dohme LLC	—	Food and Beverage	In-kind items and services	$25.00	General
10/25/2023	Bayer Healthcare Pharmaceuticals Inc.	Adempas (Drug)	Consulting Fee	Cash or cash equivalent	$200.00	General
Category: Cardio-pulmonary
09/10/2023	United Therapeutics Corporation	TYVASO (Drug)	Food and Beverage	In-kind items and services	$35.69	General
Category: PAH
05/22/2023	United Therapeutics Corporation	TYVASO (Drug)	Food and Beverage	In-kind items and services	$32.42	General
Category: PAH
05/21/2023	United Therapeutics Corporation	TYVASO (Drug)	Food and Beverage	In-kind items and services	$118.55	General
Category: PAH
04/12/2023	Merck Sharp & Dohme LLC	—	Consulting Fee	Cash or cash equivalent	$450.00	General
Category: CARDIOVASCULAR
02/06/2023	United Therapeutics Corporation	TYVASO (Drug), ORENITRAM	Food and Beverage	In-kind items and services	$109.43	General
Category: PAH
11/21/2022	Merck Sharp & Dohme LLC	—	Consulting Fee	Cash or cash equivalent	$425.00	General
Category: CARDIOVASCULAR
10/26/2022	Janssen Research & Development, LLC	—	Consulting Fee	Cash or cash equivalent	$1,240.00	General
09/19/2022	Merck Sharp & Dohme LLC	—	Consulting Fee	Cash or cash equivalent	$2,790.00	General
09/12/2022	Merck Sharp & Dohme LLC	—	Consulting Fee	Cash or cash equivalent	$850.00	General
Category: CARDIOVASCULAR

1 2 3 »

Medicare Billing by Year

Year	Procedures	Beneficiaries	Services	Submitted	Medicare Paid
2023	4	145	275	$65,289	$22,848
2022	4	129	223	$62,377	$21,740
2021	5	164	307	$83,034	$29,447
2020	7	239	425	$110,608	$34,578

Total Patients

677

Total Services

1,230

Medicare Billing

$108,614

Procedure Codes

All Medicare Procedures & Services

22 procedure records from CMS Medicare Utilization

HCPCS	Description	Setting	Year	Patients	Services	Charges	Medicare Paid	Ratio
99215	Established patient office or other outpatient visit, 40-54 minutes	Facility	2023	57	103	$32,477	$12,139	37.4%
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	Facility	2023	41	106	$20,458	$6,971	34.1%
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	Facility	2023	28	47	$4,935	$1,959	39.7%
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	Facility	2023	19	19	$7,419	$1,780	24.0%
99215	Established patient office or other outpatient visit, 40-54 minutes	Facility	2022	57	94	$27,918	$10,930	39.2%
99233	Follow-up hospital inpatient care per day, typically 35 minutes	Facility	2022	32	79	$22,041	$6,875	31.2%
99232	Follow-up hospital inpatient care per day, typically 25 minutes	Facility	2022	24	34	$6,562	$2,090	31.9%
99222	Initial hospital inpatient care per day, typically 50 minutes	Facility	2022	16	16	$5,856	$1,845	31.5%
99233	Subsequent hospital inpatient care, typically 35 minutes per day	Facility	2021	49	153	$42,687	$13,944	32.7%
99215	Established patient outpatient visit, total time 40-54 minutes	Facility	2021	42	59	$17,523	$7,434	42.4%
99232	Subsequent hospital inpatient care, typically 25 minutes per day	Facility	2021	26	42	$8,106	$2,740	33.8%
99222	Initial hospital inpatient care, typically 50 minutes per day	Facility	2021	22	23	$8,418	$2,730	32.4%
99214	Established patient outpatient visit, total time 30-39 minutes	Facility	2021	14	17	$3,570	$1,559	43.7%
99214	Established patient outpatient visit, total time 30-39 minutes	Office	2021	11	13	$2,730	$1,039	38.1%
99233	Subsequent hospital inpatient care, typically 35 minutes per day	Facility	2020	52	206	$57,474	$18,093	31.5%
99214	Established patient office or other outpatient, visit typically 25 minutes	Office	2020	45	56	$11,760	$3,792	32.2%
99222	Initial hospital inpatient care, typically 50 minutes per day	Facility	2020	28	28	$10,248	$3,354	32.7%
99215	Established patient office or other outpatient, visit typically 40 minutes	Facility	2020	41	45	$13,365	$3,134	23.4%
99232	Subsequent hospital inpatient care, typically 25 minutes per day	Facility	2020	27	43	$8,299	$2,661	32.1%
99239	Hospital discharge day management, more than 30 minutes	Facility	2020	13	13	$3,744	$1,263	33.7%
99443	Physician telephone patient service, 21-30 minutes of medical discussion	Facility	2020	17	18	$2,358	$1,242	52.7%
99214	Established patient office or other outpatient, visit typically 25 minutes	Facility	2020	16	16	$3,360	$1,039	30.9%

About Dr. Paul Hassoun, M.D

Dr. Paul Hassoun, M.D is a Internal Medicine healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083664387.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Hassoun, M.D has received a total of $70,581 in payments from pharmaceutical and medical device companies, with $11,320 received in 2024. These payments were reported across 68 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($49,578).

As a Medicare-enrolled provider, Hassoun has provided services to 677 Medicare beneficiaries, totaling 1,230 services with total Medicare billing of $108,614. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.

16,000 Woodworking Plans

Step-by-step blueprints for any project. Beginner to expert.

Detailed schematics Cutting lists & materials Lifetime access — $67

★★★★★ 60-day guarantee

Get Instant Access

Practice Information

Specialty Internal Medicine
Other Specialties Pulmonary Disease
Location Baltimore, MD
Active Since 05/10/2006
Last Updated 02/07/2013
Taxonomy Code 207R00000X
Entity Type Individual
NPI Number 1083664387

Products in Payments

MK-5475 (Drug) $4,825
WINREVAIR (Biological) $388.43
TYVASO (Drug) $363.15
Adempas (Drug) $200.00
ORENITRAM (Drug) $43.05
VENTAVIS ILOPROST (Drug) $15.00

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.